This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,132,200
Identifying and countering undesirable extracellular matrix components in lesions of multiple sclerosis
CIHR · 2025 · Nominated PI
- $140,000
Defining the extracellular matrix proteome in multiple sclerosis: fibroblast-derived lumican as a novel player
CIHR · 2025 · Supervisor
- $979,200
Non-invasive near-infrared spectroscopic measures of brain oxygenation and function--a potential biomarker of disease severity and progression in Multiple Sclerosis
CIHR · 2024 · Co-investigator
Identifying and countering undesirable extracellular matrix components in lesions of multiple sclerosis
Principal investigators: Yong, Voon W
Keywords: Axonal Injury; Cspgs; Extracellular Matrix; Microglia; Neurodegeneration; Neuroprotection; Oligodendrocyte; Proteoglycans; Remyelination; Translational Medicine
Defining the extracellular matrix proteome in multiple sclerosis: fibroblast-derived lumican as a novel player
Principal investigators: Gorter, Rianne P
Keywords: Extracellular Matrix; Lumican; Multiple Sclerosis; Remyelination Failure
Non-invasive near-infrared spectroscopic measures of brain oxygenation and function--a potential biomarker of disease severity and progression in Multiple Sclerosis
Principal investigators: Dunn, Jeff F
Keywords: Brain; Functional Connectivity; Hemodynamic Coherence; Hypoxia; Inflammation; Multiple Sclerosis; Near-Infrared Spectroscopy
Unraveling the role of extracellular matrix dysregulation in age-related fibrotic and inflammatory pulmonary disease
Principal investigators: Kai, FuiBoon
Keywords: Actomyosin Network; Age-Related Diseases; Biophysical Properties Of Cells; Extracellular Matrix; Idiopathic Pulmonary Fibrosis; Inflammation; Mechanosignaling; Tissue Stiffness
A novel inhibitor of remyelination in multiple sclerosis: fibulin-2
Principal investigators: Ghorbanigazar, Samira
Keywords: Multiple Sclerosis; Remyelination
Identification and mitigation of oxidized phospholipids as a novel mediator of neurodegeneration in the central nervous system.
Principal investigators: Dong, Yifei
Keywords: Flow Cyometry; Inflammation; Microglia; Microscopy; Mouse Model; Multiple Sclerosis; Neurodegeneration; Oxidized Phosphatidylcholine; Rna Sequencing; Spinal Cord
CSPG targeting for lesion regeneration in multiple sclerosis.
Principal investigators: Yong, Voon W
Keywords: April; Cspgs; Extracellular Matrix; Inhibitors; Models; Multiple Sclerosis; Oligodendrocyte; Regeneration; Remyelination; Scars
Harnessing neuroinflammation to develop new treatments for multiple sclerosis and glioblastoma
Principal investigators: Yong, Voon W
Keywords: Chondroitin Sulfate Proteoglycans; Extracellular Matrix; Glioblastoma; Innate Immunity; Leukocyte Trafficking; Multiple Sclerosis; Neuroimmunology; Phase I/Iia Clinical Trial; Remyelination; Translational Medicine
Alberta MS Network 2018 Scientific Forum
Principal investigators: Yong, Voon W
Keywords: Cell Biology; Dissemination; Imaging; Mri; Multiple Sclerosis; Neuroimmunology; Translational Science
Mobilizing anti-tumor microglia/macrophages with niacin to improve the prognosis of glioblastoma: Bench to clinical trial and back.
Principal investigators: Yong, Voon W
Keywords: Bench To Bedside; Brain Tumor; Cancer; Compromised Immunity; Glioma; Macrophages; Microglia; Mri; Neuroimmunology; Niacin
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.